Merck & Co., Inc., based in Kenilworth, New Jersey, publishes statements that contain forward-looking information. These statements, made within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, are based on current beliefs and expectations of the company’s management.
Understanding Forward-Looking Statements
These statements are not guarantees of future performance. The success of pipeline products, for example, is not assured and depends on receiving necessary regulatory approvals and proving commercially viable. If the assumptions underlying these statements prove inaccurate, or if risks and uncertainties materialize, actual results could differ significantly from what is currently projected.
A range of risks and uncertainties could affect the company’s performance. These include general industry conditions, competition, economic factors like interest and currency rates, pharmaceutical regulations, healthcare legislation, and global cost containment trends.
Technological advancements and the actions of competitors – including new products and patents – as well pose potential risks. Challenges in new product development, including securing regulatory approval, and the ability to accurately predict market conditions are further considerations. Manufacturing issues, international economic instability, and potential litigation are also cited as factors.
Merck & Co., Inc. Does not commit to publicly updating these forward-looking statements, even if new information becomes available or events unfold. The information provided is considered current as of the date presented, and investors are cautioned against relying on it as accurate after that date.
Frequently Asked Questions
What are “forward-looking statements”?
These are statements based on the company’s current beliefs and expectations, but they are not guarantees of future results.
What types of risks could affect the company’s performance?
Risks include general industry conditions, competition, economic factors, regulations, technological advances, and litigation.
Does the company plan to update these statements?
No, the company undertakes no obligation to publicly update any forward-looking statement.
Given the numerous factors that could influence future outcomes, how might investors best approach evaluating information released by companies in the pharmaceutical sector?
